Doctors Without Borders says virus cannot be contained without massive mobilization of resources to West Africa.
Amgen’s investigational treatment for secondary hyperparathyroidism in patients with chronic kidney disease who are receiving hemodialysis achieved its primary and secondary endpoints in a second Phase 3 study.
Key points from the Infectious Diseases Society of America’s updated guidelines for vaccination of immunocompromised individuals.
The viral Ice Bucket Challenge and the first effort to estimate the prevalence of amyotrophic lateral sclerosis have raised awareness of the neurodegenerative disease.
The FDA has granted approval to Genzyme’s eliglustat (Cerdelga), the only first-line oral therapy for patients with Type 1 Gaucher disease.
A new drug was recently given tentative approval by the FDA to help patients with both type 1 and type 2 diabetes.
Patients continue to benefit from high-dose atorvastatin therapy for at least 5 years after acute coronary syndrome, according to a new study.